Cogentix Medical Inc is a global medical device company that develops, manufactures, and markets urology and gynecology devices. Cogentix also commercializes the Urgent PC Neuromodulation System, an FDA-cleared device that delivers percutaneous tibial nerve stimulation for the office-based treatment of overactive bladder.

After investing in the Israeli company Vensica Medical, Cogentix opened a dedicated urology research and development center in Israel. The center focuses on developing next-generation products using the depth of experienced medical professionals in the area.